Efficacy of Protamine Zinc Recombinant Human Insulin for Controlling Hyperglycemia in Dogs with Diabetes Mellitus

被引:25
作者
Della Maggiore, A. [2 ]
Nelson, R. W. [1 ]
Dennis, J.
Johnson, E. [4 ]
Kass, P. H. [3 ]
机构
[1] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA
[2] Univ Calif Davis, Vet Med Teaching Hosp, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA
[4] Univ Calif Davis, Dept Surg & Radiol Sci, Sch Vet Med, Davis, CA 95616 USA
关键词
Fructosamine; Glucose; Hypoglycemia; Pancreas; PHARMACOKINETICS; SUSPENSION; RESISTANCE; DIAGNOSIS; SAFETY;
D O I
10.1111/j.1939-1676.2011.00861.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Alternative insulin preparations are needed when NPH insulin is ineffective in diabetic dogs. This study evaluated the efficacy of recombinant human protamine zinc insulin (rhPZI) for treating diabetic dogs. Hypothesis: rhPZI is effective for treating diabetic dogs. Animals: Six newly diagnosed and 11 insulin-treated diabetic dogs. Methods: Prospective clinical trial. Dogs were treated with rhPZI for 60 days. Control of glycemia was assessed on days 7, 14, 30, and 60 by evaluation of history, physical examination, body weight, serum fructosamine concentration, and blood glucose concentrations measured before and 2, 4, 6, 8, and 10 hours after rhPZI administration. Adjustments in dosage of rhPZI were made as needed to control glycemia. Results: rhPZI administration resulted in a significant decrease in 10-hour mean blood glucose (MBG(10h); 299 +/- 115 versus 457 +/- 38 mg/dL, X +/- SD, P = .0003) and serum fructosamine (478 +/- 83 versus 557 +/- 104 mu mol/L, P = .006) concentration at day 60, compared with day 1, respectively. By day 60, polyuria and polydipsia had improved in 14, body weight was stable or increased in 16, MBG(10h) had decreased in 16, and serum fructosamine concentration had decreased in 11 of 17 dogs, compared with day 1. Hypoglycemia (< 80 mg/dL) was the only consistent adverse event. Conclusions and Clinical Relevance: rhPZI is effective in diabetic dogs and can be considered as an alternative treatment in diabetic dogs that are poorly controlled using other insulin preparations.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 19 条
[2]   Evaluation of six portable blood glucose meters for measuring blood glucose concentration in dogs [J].
Cohen, Todd A. ;
Nelson, Richard W. ;
Kass, Philip H. ;
Christopher, Mary M. ;
Feldman, Edward C. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2009, 235 (03) :276-280
[3]   Anti-Insulin Antibodies in Diabetic Dogs Before and After Treatment with Different Insulin Preparations [J].
Davison, L. J. ;
Walding, B. ;
Herrtage, M. E. ;
Catchpole, B. .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (06) :1317-1325
[4]  
FELDMAN EC, 1982, J AM VET MED ASSOC, V180, P1432
[5]   Pharmacokinetics and pharmacodynamics of porcine insulin zinc suspension in eight diabetic dogs [J].
Fleeman, L. M. ;
Rand, J. S. ;
Morton, J. M. .
VETERINARY RECORD, 2009, 164 (08) :232-237
[6]   Insulin Resistance in Dogs [J].
Hess, Rebecka S. .
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2010, 40 (02) :309-+
[7]   Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993-1998) [J].
Hess, RS ;
Ward, CR .
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2000, 216 (02) :217-221
[8]   Analytical validation of an ELISA for measurement of canine pancreas-specific lipase [J].
Huth, Stacey P. ;
Relford, Roberta ;
Steiner, Joerg M. ;
Strong-Townsend, Marilyn I. ;
Williams, David A. .
VETERINARY CLINICAL PATHOLOGY, 2010, 39 (03) :346-353
[9]   Distinct pharmacodynamics of insulin glargine and insulin detemir: Crossover comparison in Type 1 and Type 2 diabetic patients on basal-bolus regimen [J].
Kato, Tomoko ;
Tokubuchi, Ichiro ;
Muraishi, Kazuhisa ;
Sato, Shuichi ;
Kato, Tamotsu ;
Hara, Kento ;
Tanaka, Kayo ;
Kaku, Hiroo ;
Tajiri, Yuji ;
Yamada, Kentaro .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) :E64-E66
[10]  
LORENZEN FH, 1992, ACTA VET SCAND, V33, P219